Anthropic Acquires Mithril Medicine to Expand Its Drug Development Work

Anthropic has acquired Mithril Medicine, a one-person biotech pursuing treatments for two rare forms of muscular dystrophy. The acquisition brings the startup’s Claude-assisted research into Anthropic’s first in-house drug development programs. The deal closed in July and was disclosed on October 27; financial terms were not disclosed, according to the acquisition report.